UCLA Division of Hematology Oncology — Los Angeles, California

UCLA Division of Hematology Oncology is a clinical research site located in Los Angeles, California, United States 90095-1752.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

UCLA Division of Hematology Oncology has participated in 5 clinical trials.

Therapeutic areas: Carcinoma, Hepatocellular, Multiple Myeloma, Leukemia, Myeloid, Acute.

Sponsors: Celgene, CARGO Therapeutics.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Division of Hematology Oncology?

UCLA Division of Hematology Oncology has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Division of Hematology Oncology conducted?

UCLA Division of Hematology Oncology has 5 clinical trials on record. Their work covers Carcinoma, Hepatocellular, Multiple Myeloma, Leukemia, Myeloid, Acute.

Is UCLA Division of Hematology Oncology accredited by Crixeo Health?

UCLA Division of Hematology Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Division of Hematology Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.